Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Orasure Technologies ( (OSUR) ).
OraSure Technologies announced the acquisition of Sherlock Biosciences, a move that is expected to enhance their portfolio with next-generation molecular diagnostics. This strategic acquisition aligns with OraSure’s mission to improve access and affordability in healthcare through innovative, instrument-free molecular self-tests, potentially increasing their revenue starting in 2026, subject to regulatory approvals.
More about Orasure Technologies
YTD Price Performance: -53.78%
Average Trading Volume: 672,716
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $282.7M
Learn more about OSUR stock on TipRanks’ Stock Analysis page.
